We are live on ! Find out more
FTH

Faeth Therapeutics
FTH

37 hedge funds and large institutions have $19.7M invested in Faeth Therapeutics in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 8

0.02% less ownership

Funds ownership: 0.58% → 0.56% (-0.02%)

12% less funds holding

Funds holding: 42 → 37 (-5)

31% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 13

47% less capital invested

Capital invested by funds: $37.1M → $19.7M (-$17.3M)

Holders
37
Holders Change
-5
Holders Change %
-11.9%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
15
Reduced
8
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$1.51M
2
State Street
State Street
Massachusetts
+$316K
3
Morgan Stanley
Morgan Stanley
New York
+$250K
4
Two Sigma Investments
Two Sigma Investments
New York
+$215K
5
UBS Group
UBS Group
Switzerland
+$160K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$1.3M
2
Millennium Management
Millennium Management
New York
-$1.28M
3
MCM
Moore Capital Management
New York
-$519K
4
AA
ALPS Advisors
Colorado
-$394K
5
MCCP
Mission Creek Capital Partners
California
-$345K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$6.97M +$1.51M +10,120 +20%
Vanguard Group
2
Vanguard Group
Pennsylvania
$4.37M +$51.8K +347 +0.9%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$1.49M -$130K -873 -6%
State Street
4
State Street
Massachusetts
$1.22M +$316K +2,113 +25%
Northern Trust
5
Northern Trust
Illinois
$928K -$6.72K -45 -0.6%
JP Morgan Chase
6
JP Morgan Chase
New York
$926K -$71.4K -478 -6%
DFO
7
Duquesne Family Office
New York
$580K – – –
Millennium Management
8
Millennium Management
New York
$506K -$1.28M -8,568 -66%
Bank of New York Mellon
9
Bank of New York Mellon
New York
$322K +$62.6K +419 +18%
Truist Financial
10
Truist Financial
North Carolina
$293K -$149K -997 -28%
N
11
Nuveen
North Carolina
$271K -$35.9K -240 -9%
Charles Schwab
12
Charles Schwab
California
$255K -$20.3K -136 -6%
Morgan Stanley
13
Morgan Stanley
New York
$214K +$250K +1,676 +1,010%
Two Sigma Investments
14
Two Sigma Investments
New York
$167K +$215K +1,439 New
Bank of America
15
Bank of America
North Carolina
$146K +$123K +826 +194%
UBS Group
16
UBS Group
Switzerland
$130K +$160K +1,070 +2,140%
Two Sigma Advisers
17
Two Sigma Advisers
New York
$116K +$149K +1,000 New
RhumbLine Advisers
18
RhumbLine Advisers
Massachusetts
$110K +$17.3K +116 +14%
VF
19
Virtu Financial
New York
$93K +$119K +799 New
Deutsche Bank
20
Deutsche Bank
Germany
$74K +$4.93K +33 +5%
CSS
21
Cubist Systematic Strategies
Connecticut
$74K +$95.6K +640 New
JF
22
Jump Financial
Illinois
$68K +$88.2K +590 New
California State Teachers Retirement System (CalSTRS)
23
California State Teachers Retirement System (CalSTRS)
California
$65K – – –
AIG
24
American International Group
New York
$64K -$2.54K -17 -3%
Goldman Sachs
25
Goldman Sachs
New York
$64K +$82.9K +555 New
1
2

FTH Hedge Fund Activity: Q4 2021 in Review

37 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Faeth Therapeutics (FTH) for Q4 2021, worth a combined $19.7M — down 47% from $37.1M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of FTH and 9 opened new positions — a net loss of 4 holders — while 8 trimmed existing stakes and 15 added.

The largest buyer was BlackRock, adding an estimated $1.51M. The largest seller was Citadel Advisors, exiting entirely with an estimated $1.3M sold.

  • 37 institutional investors held Faeth Therapeutics (FTH) as of Q4 2021, down from 42 in Q3 2021.
  • Funds reported $19.7M of Faeth Therapeutics stock for Q4 2021, down 47% quarter-over-quarter.
  • 9 funds opened new Faeth Therapeutics positions in Q4 2021 and 13 closed out, a net change of -4 holders.
  • The largest Faeth Therapeutics buyer in Q4 2021 was BlackRock, an estimated $1.51M added.
  • The largest Faeth Therapeutics seller in Q4 2021 was Citadel Advisors, an estimated $1.3M sold.

Based on aggregated 13F filings for Q4 2021.